Compare Logitech International SA (LOGI) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Logitech International SA vs 10X Genomics Inc — how do they compare? Logitech International SA trades at $101.7 (market cap $14.65B), while 10X Genomics Inc trades at $47.2 (market cap $5.48B). The key difference: Logitech International SA is far larger — about 2.7× 10X Genomics Inc's market cap, and Logitech International SA pays a 1.67% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| LOGI | TXG | |
|---|---|---|
Market Cap | $14.65B | $5.48B |
Sector | Technology | Health |
52-Week High | $126.69 | $45.80 |
52-Week Low | $85.84 | $11.34 |
Enterprise Value | $13.00B | $5.02B |
Dividend Yield | 1.67% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
